Browsing by Author "Ramos, C."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Cyber pornography use inventory-9: factor structure and psychometric properties in the Portuguese populationPublication . Cardoso, J.; Ramos, C.; Almeida, T.; Gomes, A.; Fernandes, A.; Ribeiro, R.Online pornography is characterized by easy and anonymous accessibility, as well as free or low cost. The impact of pornography depends on the type of content consumed, the frequency of exposure, and the personal and contextual characteristics of users. Several, mainly negative, effects have been reported, related to exposure to pornography, including more permissive sexual norms, inappropriate attitudes towards gender roles, unrealistic expectations, decreased sexual interest in the partner, lower relational and sexual satisfaction, sexual addiction, and devaluation or legitimation of sexual violence.
- Perceived addiction to online pornography and sexual attitudes in Portuguese college studentsPublication . Gomes, A.; Fernandes, A.; Ribeiro, R.; Cardoso, J.; Ramos, C.There is evidence that sexual attitudes are linked to viewing online pornography, but an operational definition of online pornography problematic use doesn’t exist. College students are usually associated with more permissive sexual attitudes that elicit a greater acceptance of internet pornography, which can be addictive. The main objective of this study was to characterize the use of online pornography and sexual attitudes in Portuguese college students, confirming if they are related and analyzing if these variables differ according to sociodemographic aspects: gender, sexual orientation, marital status, romantic relationship and educational level.
- The cancer registry as an ally in monitoring treatment effectivenessPublication . Costa, F. A.; Ramos, C.; Murteira, R.; Almodovar, T.; Passos-Coelho, J. L.; Carvalho, M. I.; Costa, L.; Brito, M. J.; Ramos, S.; Ferreira, M.; Miranda, A. C.OBJECTIVE: To evaluate if the cancer registry database can be used to monitor treatment effectiveness using nivolumab treatment of non-small cell lung cancer (NSCLC) as an example. METHOD: An observational inception cohort was used, where all registered cases of NSCLC with authorisation to initiate treatment with nivolumab were monitored retrospectively to evaluate disease characteristics and response to prior treatments. Current exposure to nivolumab was prospectively characterised and treatment outcomes classified based on the clinical information registered in the patient medical record. The main outcome measure used to assess treatment effectiveness was overall survival (OS). Secondary outcomes considered were progression free survival (PFS) as a measure of effectiveness and occurrence of Adverse Drug Reaction (ADRs) as a measure of safety. Data were analysed using SPSS, version 24. RESULTS: A total of 115 patients received treatment with nivolumab for NSCLC, between November 1st 2015 and July 31st 2016, and were registered in the database. The majority were non-squamous type (n=107). The median OS was 11.4 months {CI95%: 11.1-11.7}, with a 1-year survival of 44%, in line with clinical trial data. Median PFS was 5.4 months {CI95%: 2.8-7.9}. Treatment was discontinued in 82 cases, most frequently due to disease progression. There were 38 cases of ADRs documented in the patient medical chart, 21 of which led to treatment discontinuation. CONCLUSION: The analysed data suggest that the cancer registry is a powerful tool to monitor treatment effectiveness, although considerable investment is needed to improve the medical culture of recording treatment exposure, particularly documentation of ADRs.